GWS
GRTS

Glassman Wealth Services’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Glassman Wealth Services’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39
Closed – – 1430
2019
Q2 		$0 Buy
+39
New +$446 ﹤0.01% 1424

Other funds holding GRTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Glassman Wealth Services's GRTS Position: Q3 2019 in Review

Glassman Wealth Services sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2019, closing a stake of 39 shares.

Glassman Wealth Services first reported a position in GRTS in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 61 funds tracked by Wall St. Rank hold GRTS as of Q3 2019.

  • Glassman Wealth Services reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Glassman Wealth Services sold 39 Gritstone bio, Inc. Common Stock shares in Q3 2019.
  • Glassman Wealth Services first reported a position in Gritstone bio, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Glassman Wealth Services's Gritstone bio, Inc. Common Stock position peaked at $0 in Q2 2019.
  • 61 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2019.

Based on Glassman Wealth Services's 13F filing for Q3 2019, filed 1 Nov 2019.